Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Zika Virus Infection

ClinicalTrials.gov lists 77 trials for Zika Virus Infection or a narrower condition beneath it. National Institute of Allergy and Infectious Diseases (NIAID) has the most among industry and government lead sponsors, with 12.

MeSH D000071243 Infections C01 Listed by Orphanet as a rare disease
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 21 Phase 2 Phase 2 2 Phase 3 Phase 3 1 Not applicable Not applicable 19 Observational Observational 34 Phase 1 Phase 1 21 Phase 2 Phase 2 2 Phase 3 Phase 3 1 Not applicable Not applicable 19 Observational Observational 34

Trials per phase (log scale)

77 of the 77 trials are tagged with Zika Virus Infection itself; the rest are tagged with a narrower condition beneath it.

Get the Zika Virus Infection report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Zika Virus Infection trials start? (14)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 1
  • Phase 2
  • Phase 3
  • Not applicable
  • Observational

Top of scale: 18

2010: 1 trials (Observational 1) 2011: 1 trials (Observational 1) 2015: 1 trials (Not applicable 1) 2016: 18 trials (Observational 12, Phase 1 6) 2017: 17 trials (Observational 7, Not applicable 4, Phase 3 1, Phase 2 1, Phase 1 4) 2018: 11 trials (Observational 4, Not applicable 3, Phase 1 4) 2019: 6 trials (Observational 2, Not applicable 1, Phase 1 3) 2020: 5 trials (Observational 2, Not applicable 2, Phase 1 1) 2021: 6 trials (Observational 2, Not applicable 3, Phase 2 1) 2022: 2 trials (Not applicable 1, Phase 1 1) 2023: 2 trials (Observational 1, Not applicable 1) 2024: 3 trials (Not applicable 1, Phase 1 2) 2025: 3 trials (Observational 2, Not applicable 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 1
2025 3
2024 3
2023 2
2022 2
2021 6
2020 5
2019 6
2018 11
2017 17

No forecast is made for this condition: it averages 2.2 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Zika Virus Infection trials in? (5)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 21
Phase 2 2
Phase 3 1
Not applicable 19
Observational 34

How many Zika Virus Infection trials are recruiting? (8)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Not yet recruiting 1
Recruiting 2
Enrolling by invitation 2
Completed 58
Suspended 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Zika Virus Infection trials? (7)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
National Institute of Allergy and Infectious Diseases (NIAID) 12
Institut Pasteur 3
ModernaTX, Inc. 3
GeneOne Life Science, Inc. 2
Themis Bioscience GmbH 2

Interventions as named in the registry (15)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Zika Virus Purified Inactivated Vaccine 4
VLA1601 2
mRNA-1893 2
GLS-5700 2
Biological sample collection 2

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which serious adverse events do Zika Virus Infection trials report? (10)

Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.

Serious adverse events in this condition's trials
Adverse event Subjects affected Trials
Appendicitis 7 2
Cellulitis 5 3
Depression 3 2
Major depression 3 3
Abortion spontaneous 2 2

Which publications cover Zika Virus Infection? (106)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Prevalence (6)

Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.

Prevalence
Orphanet disease Type Class Geography Jurisdiction Mapping relation
Zika virus disease Point prevalence Unknown Worldwide Not stated Exact
Zika virus disease Annual incidence 1-5 / 10 000 Brazil Not stated Unspecified
Zika virus disease Point prevalence Unknown Worldwide Not stated Unspecified
Zika virus disease Annual incidence 1-5 / 10 000 Brazil Not stated Exact
Zika virus disease Annual incidence 1-5 / 10 000 Brazil Not stated Exact

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Zika virus disease 448237 Exact Orphanet Rare Disease Ontology (ORDO)
Zika virus disease 448237 Exact Orphadata Science knowledge files, Product 1

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: sub-conditions in mesh.

Browse all condition evidence pages